Integration of automated morphological features resolves a distinct group of atypical chronic lymphocytic leukemias with chromosomal aberrations.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis

• Publication date

  2014-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.leukres.2014.01.008PMID 24565568
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols

  2012cited by this paper
• EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes

  2012cited by this paper
• EuroFlow: Resetting leukemia and lymphoma immunophenotyping. Basis for companion diagnostics and personalized medicine

  2012cited by this paper
• Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemia.

  2010cited by this paper
• GENOMIC ABERRATIONS AND SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKEMIA

  2010cited by this paper
• Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia.

  2009cited by this paper
• Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.

  2008cited by this paper
• Analysis of CD23 antigen expression in B-chronic lymphocytic leukaemia and its correlation with clinical parameters

  2008cited by this paper
• Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: a universally available prognostic test.

  2007cited by this paper
• The t(14;19)(q32;q13)‐positive small B‐cell leukaemia: a clinicopathologic and cytogenetic study of seven cases

  2007cited by this paper
• Albumin enhanced morphometric image analysis in CLL

  2004cited by this paper
• ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

  2003cited by this paper
• Quantitative flow cytometry for the differential diagnosis of leukemic B‐cell chronic lymphoproliferative disorders

  2000cited by this paper
• Genomic aberrations and survival in chronic lymphocytic leukemia.

  2000cited by this paper
• The concept of typical and atypical chronic lymphocytic leukaemia.

  1999cited by this paper
• Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases

  1997cited by this paper
• Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients

  1996cited by this paper
• National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment.

  1996cited by this paper
• Clinical, biological, and immunophenotypical characteristics of B-cell chronic lymphocytic leukemia with trisomy 12 by fluorescence in situ hybridization.

  1995cited by this paper
• Trisomy 12 is uncommon in typical chronic lymphocytic leukaemias

  1994cited by this paper
• The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.

  1994cited by this paper
• Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: analysis by stage, immunophenotype, and morphology.

  1993cited by this paper
• Chronic lymphocytic leukaemia: prognostic value of lymphocyte morphological subtypes. A multivariate survival analysis in 146 patients

  1991cited by this paper
• CD23 ANTIGEN EXPRESSION IN CLL

  1989cited by this paper
• Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.

  1989cited by this paper
• Heterogeneity of CLL: high CD23 antigen and αIFN receptor expression are features of favourable disease and of cell activation

  1988cited by this paper
• The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia

  1986cited by this paper
• The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia

  1986cited by this paper
• Investigation of cell size and nuclear clefts as prognostic parameters in chronic lymphocytic leukemia

  1986cited by this paper

• Red and white blood cell morphology characterization and hands-on time analysis by the digital cell imaging analyzer DI-60

  2022cites this paper
• Prognostic significance of smudge cell percentage in chronic lymphocytic leukemia. Facts or artifacts? Methodological considerations and literature review

  2022cites this paper
• Smudge Cells in Chronic Lymphocytic Leukemia: Pathophysiology, Laboratory Considerations, and Clinical Significance.

  2021cites this paper
• Digital morphology analyzers in hematology: Comments on the ICSH review and recommendations

  2020cites this paper
• Hematopathology

  2020cites this paper
• Digital morphology analyzers in hematology: ICSH review and recommendations

  2019cites this paper
• Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia

  2017cites this paper
• Measurement of lymphocyte aggregation by flow cytometry–physiological implications in chronic lymphocytic leukemia

  2016cites this paper